Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs.
@article{Misselbrook2012OutWT, title={Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs.}, author={G. Misselbrook and E. J. Hamilton}, journal={Acute medicine}, year={2012}, volume={11 3}, pages={ 157-60 } }
Methoxydine (4-MeO-PCP) and Methoxetamine (3-MeO-2-Oxo-PCE) are both commercially produced designer drugs with structural and biochemical similarities to phencyclidine (PCP). Although phencyclidine toxicity is well documented, its recreational use in present times is rare. With the advent of new designer drugs being available widely through internet sites, Acute Physicians should be aware of the clinical features and management of these potential toxins. We present a case of methoxydine… CONTINUE READING
Topics from this paper
9 Citations
Two Cases of Non-fatal Intoxication with a Novel Street Hallucinogen: 3-Methoxy-Phencyclidine.
- Chemistry, Medicine
- Journal of analytical toxicology
- 2017
- 11
- PDF
Phencyclidine analog use in Sweden—intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project
- Medicine
- Clinical toxicology
- 2015
- 40
- PDF
Nephrotoxic effects of designer drugs: synthetic is not better!
- Medicine
- Nature Reviews Nephrology
- 2014
- 37
Phencyclidine-Based New Psychoactive Substances.
- Psychology, Medicine
- Handbook of experimental pharmacology
- 2018
- 12
A Polydrug Intoxication Involving Methoxetamine in a Drugs and Driving Case
- Medicine
- Journal of forensic sciences
- 2014
- 17
- PDF